The five-year exclusive agreement will allow B. Braun customers to access the full line of BodyGuard electronic infusion pumps. The product portfolio includes capabilities in therapy settings, green power options and on-pump history capability.
Read the release on the agreement between CME America and B. Braun.
More Coverage on B. Braun:
B. Braun Launches Advanced Apheresis Therapy System
B. Braun Receives FDA 510(k) Clearance for New DUPLEX System Use
B. Braun Receives Permanent Injunction in Patent Infringement Case
